Track topics on Twitter Track topics that are important to you
United States of America
Science and health information analytics business Elsevier has finalised the name of six companies that will join its innovation hub...Read More... The post Elsevier adds six start-ups to its pharma i...
Start-ups working on a range of technologies and discoveries — from AI to immunotherapy — receive complimentary access to Elsevier's information solutions to accelerate innovation
Start-ups working on a range of technologies and discoveries - from AI to immunotherapy - receive complimentary access to Elsevier's information solutions to accelerate innovation
CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018 Reporter: Aviva Lev-Ari, PhD, RN ANNOUNCEMENT Leaders in Pharmaceutical Business Intelligence (LPBI) Group is a selected CHI ...
(Elsevier) Two new chemistry solutions that use guava leaves to combat food spoilage and turn fish bones into phosphate rich fertilizer won the Elsevier Foundation Green and Sustainable Chemistry Chal...
A new analysis of safety reporting data by analytics group Elsevier and Bayer has found that some animal tests are far more predictive of human response than others.
Global information analytics business, Elsevier, has revealed that six biotech and pharma start-ups have been selected to join its innovation initiative, The Hive.
Ian Churcher, vice president of drug discovery at BenevolentAI, argues that pharma needs to embrace artificial…
CaraDerma acne treatment
Fluoride Chewable Tablets 0.5 mg
Fluoride Chewable Tablets 1 mg
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
This article has been removed: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been removed at the request ...
Drug discovery encompasses processes ranging from target selection and validation to the selection of a development candidate. While comprehensive drug discovery work flows are implemented predominant...
Many medical information systems record data about the executed process instances in the form of an event log. In this paper, we present a framework, able to convert actions in the event log into high...
The objective of this paper is to identify the extent to which real world data (RWD) is being utilized, or could be utilized, at scale in drug development. Through screening peer-reviewed literature, ...
The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...
Elsevier MDL is the pioneering leader in discovery informatics. Over 1,000 life science companies supercharge their discovery engines with MDL software solutions to generate fresh ideas and make break...
Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium(TM), Beilstein and Reaxys databases...
Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Tr...
Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, and Reaxys databases. Trademarks i...
We have published hundreds of PHARMA DISCOVERY An Elsevier Event news stories on BioPortfolio along with dozens of PHARMA DISCOVERY An Elsevier Event Clinical Trials and PubMed Articles about PHARMA DISCOVERY An Elsevier Event for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PHARMA DISCOVERY An Elsevier Event Companies in our database. You can also find out about relevant PHARMA DISCOVERY An Elsevier Event Drugs and Medications on this site too.